| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |